Trial
NCT03149120
Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
NYU Langone Health
Collaborators
Bristol-Myers Squibb
Condition
Soft Tissue Sarcomas
Intervention
Nivolumab
Why stopped
No patient enrolled as new similar study will be in system within 3 months
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-22